Epistem is a biotechnology company with a specialist understanding of epithelial tissue and stem cell analyses, operating three distinct business divisions. The Contract Research Division delivers innovative preclinical research services in the areas of oncology, mucositis,inflammatory bowel disease, wound healing and skincare. Working with over 130 pharmaceutical, biotechnology and personal care companies worldwide, it offers proprietary assays for target validation, screening, efficacy and translational biology.
The Personalised Medicine Division is committed to facilitating a more tailored approach to patient treatment and care. It applies innovative gene expression technology to discovering novel drug-induced biomarkers to GCLP standard and has recently launched this technology in kit form as RNA-Amp®. It has also developed Genedrive™, a ‘point of care’ molecular diagnostic device providing a ‘near patient’ diagnosis in less than 30 minutes using hand-held apparatus. Our Novel Therapies Division is identifying the key regulators (proteins and peptides) of epithelial stem cells with the aim of developing therapeutics to control cell production
Contact us on 0161 606 7258 or email@example.com